A new study led by Angela Bryan, a CU Boulder professor and cancer survivor, is among the first to assess how cannabis bought over the counter is used by cancer survivors. The study examined 1,886 cancer survivors, revealing that nearly half of them had either currently or previously used cannabis.
Results showed that more than 500 participants treated their symptoms with cannabis. The study findings indicate that patients with cancer perceived benefits to using cannabis for many symptoms, including pain relief and improved sleep. However, it also revealed that those who used cannabis were more likely to have higher levels of depression and anxiety.
Journalist Tom Brokaw, 83, recently shared his experience of resorting to medical marijuana to manage pain amid his multiple myeloma diagnosis. His story highlights the growing trend of cancer patients turning to cannabis as an alternative or complementary treatment option.
The new research project aims to assess the benefits and potential harms of medical cannabis and cannabinoids in breast cancer patients during and after treatment. This study aims to provide valuable insights into the effectiveness and safety of cannabis as a therapeutic option.
Cannabis has been found to relieve pain, improve sleep, and lift brain fog in cancer patients. Many individuals with cancer who use cannabis to reduce symptoms have reported positive outcomes. However, it is essential to note that further research is needed to fully understand the potential benefits and risks.
A significant concern regarding cannabis use is its potential to cause lung issues and even lung cancer. It is crucial for cancer patients and survivors to be aware of these risks and make informed decisions about their treatment options.
Factors informing individualized treatment decision-making for HER2-positive metastatic breast cancer include the use of cannabis. Patients with cancer who used cannabis as part of their treatment plan reported experiencing various benefits, such as improved quality of life and symptom management.
The study's findings highlight the need for healthcare providers to have open discussions with cancer patients regarding cannabis use. It is vital for patients to receive accurate information about the potential benefits and risks of using cannabis as part of their treatment plan.
The use of cannabis among cancer survivors is a complex issue that requires further scientific investigation. Researchers are continually working to better understand the potential benefits and risks associated with cannabis use in cancer patients.
As the legalization of cannabis continues to expand across the United States, it is crucial to have evidence-based information available to guide cancer patients and survivors in making informed decisions about their treatment options.
The study's findings also highlight the need for comprehensive education and support programs for cancer patients and survivors who choose to use cannabis as part of their treatment plan. These programs can provide guidance on safe and responsible use, potential interactions with other medications, and potential side effects.
It is essential for cancer patients and survivors to consult with their healthcare providers before incorporating cannabis into their treatment plan. Healthcare professionals can provide personalized guidance and ensure that cannabis use is integrated safely and effectively.
In conclusion, cannabis use among cancer survivors is a topic that necessitates further research and understanding. While many patients perceive benefits from using cannabis to manage symptoms, it is crucial to balance these potential benefits with the known risks associated with cannabis use.
As the medical and legal landscape surrounding cannabis evolves, it is essential for healthcare providers, researchers, and policymakers to continue exploring the potential benefits and risks of cannabis use in cancer patients. This knowledge will empower patients to make informed decisions about their treatment options and improve overall patient care.
